Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146819653> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2146819653 abstract "Background: Osteogenesis imperfecta (OI) is an inherited connective tissue disorder with defective bone quality leading to increased bone fragility and low bone mass. Menatetrenone has been shown to reduce bone mineral density (BMD) loss as well as the incidence of fractures in patients with osteoporosis. Objectives: We investigated the effects of menatetrenone in five prepubertal children with OI. Methods: All patients had been treated with intravenous pamidronate for four to 42 months prior to enrollment in this study. Pamidronate was discontinued at least two months before starting 15 milligrams per day of oral menatetrenone. Menatetrenone was given for 12 months. BMD was measured at baseline and one year after menatetrenone treatment. Results: During one year of menatetrenone treatment, the incidence of fractures was 1.0 (0.0-2.0) times/year, which was not significantly different from the fracture rate of 1.2 (0.0-1.5) times/year during pamidronate treatment. However, it significantly decreased compared with the fracture rate of 10.4 (2.7-47.6) times/year before pamidronate treatment (P=0.043). After one year of menatetrenone, BMD of lumbar spine and left hip significantly increased in three and two patients, respectively. However, one patient showed a significant decrease in BMD in both regions. Noteworthy, none of the patients developed adverse side effects during menatetrenone treatment. Conclusions: One-year menatetrenone could maintain the decreased fracture rate of intravenous pamidronate in prepubertal OI patients. No adverse effects were observed. Larger and longer studies to determine the benefit of oral menatetrenone as adjunctive treatment in OI patients are warranted. Keywords: Fracture, menatetrenone, osteogenesis imperfecta, pamidronate" @default.
- W2146819653 created "2016-06-24" @default.
- W2146819653 creator A5040292522 @default.
- W2146819653 date "2012-01-26" @default.
- W2146819653 modified "2023-09-28" @default.
- W2146819653 title "Safety and efficacy of menatetrenone in children with osteogenesis imperfecta" @default.
- W2146819653 cites W1973360982 @default.
- W2146819653 cites W1977065585 @default.
- W2146819653 cites W1990123370 @default.
- W2146819653 cites W199483266 @default.
- W2146819653 cites W1997889859 @default.
- W2146819653 cites W2000165521 @default.
- W2146819653 cites W2004979463 @default.
- W2146819653 cites W2006609290 @default.
- W2146819653 cites W2011554499 @default.
- W2146819653 cites W2011610305 @default.
- W2146819653 cites W2044511994 @default.
- W2146819653 cites W2067344817 @default.
- W2146819653 cites W2075241308 @default.
- W2146819653 cites W2075721622 @default.
- W2146819653 cites W2083892795 @default.
- W2146819653 cites W2114821926 @default.
- W2146819653 cites W2137005590 @default.
- W2146819653 cites W2155919624 @default.
- W2146819653 cites W2334840727 @default.
- W2146819653 doi "https://doi.org/10.5372/9705" @default.
- W2146819653 hasPublicationYear "2012" @default.
- W2146819653 type Work @default.
- W2146819653 sameAs 2146819653 @default.
- W2146819653 citedByCount "0" @default.
- W2146819653 crossrefType "journal-article" @default.
- W2146819653 hasAuthorship W2146819653A5040292522 @default.
- W2146819653 hasConcept C120665830 @default.
- W2146819653 hasConcept C121332964 @default.
- W2146819653 hasConcept C126322002 @default.
- W2146819653 hasConcept C141071460 @default.
- W2146819653 hasConcept C142724271 @default.
- W2146819653 hasConcept C197934379 @default.
- W2146819653 hasConcept C2776541429 @default.
- W2146819653 hasConcept C2776940978 @default.
- W2146819653 hasConcept C2777668750 @default.
- W2146819653 hasConcept C2781037820 @default.
- W2146819653 hasConcept C61511704 @default.
- W2146819653 hasConcept C71924100 @default.
- W2146819653 hasConceptScore W2146819653C120665830 @default.
- W2146819653 hasConceptScore W2146819653C121332964 @default.
- W2146819653 hasConceptScore W2146819653C126322002 @default.
- W2146819653 hasConceptScore W2146819653C141071460 @default.
- W2146819653 hasConceptScore W2146819653C142724271 @default.
- W2146819653 hasConceptScore W2146819653C197934379 @default.
- W2146819653 hasConceptScore W2146819653C2776541429 @default.
- W2146819653 hasConceptScore W2146819653C2776940978 @default.
- W2146819653 hasConceptScore W2146819653C2777668750 @default.
- W2146819653 hasConceptScore W2146819653C2781037820 @default.
- W2146819653 hasConceptScore W2146819653C61511704 @default.
- W2146819653 hasConceptScore W2146819653C71924100 @default.
- W2146819653 hasIssue "1" @default.
- W2146819653 hasLocation W21468196531 @default.
- W2146819653 hasOpenAccess W2146819653 @default.
- W2146819653 hasPrimaryLocation W21468196531 @default.
- W2146819653 hasRelatedWork W1998076734 @default.
- W2146819653 hasRelatedWork W2001478403 @default.
- W2146819653 hasRelatedWork W2054043511 @default.
- W2146819653 hasRelatedWork W2056536222 @default.
- W2146819653 hasRelatedWork W2080899612 @default.
- W2146819653 hasRelatedWork W2081131401 @default.
- W2146819653 hasRelatedWork W2086444550 @default.
- W2146819653 hasRelatedWork W2086786509 @default.
- W2146819653 hasRelatedWork W2090991947 @default.
- W2146819653 hasRelatedWork W2120497442 @default.
- W2146819653 hasRelatedWork W2162844606 @default.
- W2146819653 hasRelatedWork W22499408 @default.
- W2146819653 hasRelatedWork W2289275441 @default.
- W2146819653 hasRelatedWork W2319504156 @default.
- W2146819653 hasRelatedWork W2325596401 @default.
- W2146819653 hasRelatedWork W2922490237 @default.
- W2146819653 hasRelatedWork W2948695383 @default.
- W2146819653 hasRelatedWork W3095675902 @default.
- W2146819653 hasRelatedWork W3175619170 @default.
- W2146819653 hasRelatedWork W2518652232 @default.
- W2146819653 hasVolume "6" @default.
- W2146819653 isParatext "false" @default.
- W2146819653 isRetracted "false" @default.
- W2146819653 magId "2146819653" @default.
- W2146819653 workType "article" @default.